CUL3 and NRF2 mutations confer an NRF2 activation phenotype in a sporadic form of papillary renal cell carcinoma

Aikseng Ooi, Karl Dykema, Asif Ansari, David Petillo, John Snider, Richard Kahnoski, John Anema, David Craig, John Carpten, Bin Tean Teh, Kyle A. Furge

Research output: Contribution to journalArticlepeer-review

110 Scopus citations

Fingerprint

Dive into the research topics of 'CUL3 and NRF2 mutations confer an NRF2 activation phenotype in a sporadic form of papillary renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences